Target AudienceRocgene's fluorescence quantitative PCR and molecular POCT products are suitable for clinical multi-scenario detection, highly sensitive and accurate capture of trace nucleic acids, ultra-fast and automated molecular testing. It provides efficient and comprehensive solutions for the precise diagnosis and treatment of infection, genetics and medication.

Target Audience Provide accurate and rapid disease detection and diagnosis services for hospitals, clinics, tripartite medical testing and other institutions.

Target Audience

Target AudienceRocgene gradient, fluorescence quantitative PCR and supporting molecular detection products empower multi-field scientific research in life sciences, with high sensitivity and accurate resolution, and fully adapt to the needs of gene expression analysis, typing, mutation detection, etc., helping scientific research to make efficient breakthroughs, complete the R&D and production platform of instruments and reagents, and promote the implementation and transformation of scientific research results.

Target Audience research groups, universities, research institutes and other scientific research institutions that carry out molecular mechanism research related topics;

Target Audience

Target AudienceRocgene molecular detection equipment and reagents are suitable for full-scenario detection of agriculture, forestry, fishery and animal husbandry, and highly sensitive and accurate capture of trace pathogenic nucleic acids. The integration of instruments and reagents is self-developed and self-produced, and the core technology is easy to implement and transform, empowering industrial epidemic prevention and control and quality testing and improvement, and providing efficient services for the implementation and transformation of agricultural, forestry, fishery and animal husbandry products.

Target Audience Universities and research institutes, seed companies, seed industry testing service institutions and seed industry supervision institutions that carry out molecular breeding-related topics.

Target Audience

Target AudienceRocgene's one-stop solution for nucleic acid testing is specifically suitable for the detection of animal and pet diseases, highly sensitive and accurate capture of trace amounts of pathogenic nucleic acid, extremely simple to operate, and can effectively prevent cross-infection without pollution throughout the process, and efficiently help early screening and rapid detection of pet diseases, and precise prevention and control.

Target Audience Animal husbandry and fishery breeding bases, animals, pet breeding bases, veterinary hospitals and pet medical fields provide systematic nucleic acid testing solutions.

Target Audience

Target AudienceRocgene nucleic acid testing one-stop solution, adapted to the whole scenario of health and epidemic prevention, highly sensitive and accurate capture of trace pathogenic nucleic acids, extremely simple to operate, pollution-free and cross-infection throughout the process, and efficiently helps early screening and rapid detection of epidemics and build a solid line of defense against epidemics.

Target Audience For disease surveillance, epidemic early warning, food safety and other applications, it provides systematic nucleic acid testing solutions for public health prevention and control, customs and food and drug administration.

Target Audience

Target AudienceRocgene molecular detection equipment and supporting reagents are suitable for the quality control needs of the whole process of biopharmaceuticals, with high sensitivity and accurate capture of trace nucleic acids, stable performance and reliable results, fully in line with industry regulations and requirements, complete software and hardware support, and efficient empowerment of pharmaceutical research and development, process monitoring and finished product inspection.

Target Audience For applications such as microbial contamination monitoring, preclinical research, and quality control, it provides systematic nucleic acid testing solutions for biopharmaceutical companies, contract research organizations (CROs), contract manufacturing organizations (CMOs), gene editing and cell therapy companies, quality control laboratories (owned by pharmaceutical companies or third parties), academic research institutions and translational medicine centers, and on-board regulatory institutions.

Target Audience